Understanding ADHD

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition characterized by persistent patterns of inattention, hyperactivity, and impulsivity that interfere with functioning and development. It is not a deficit of effort or willpower. The inattention characteristic of ADHD reflects differences in executive functioning — the cognitive processes that support sustained attention, working memory, planning, and impulse regulation.

ADHD presents differently across individuals. Some people experience inattention as the most prominent feature: difficulty staying on task, losing track of conversations or instructions, misplacing things, and struggling with sustained mental effort. Others experience more hyperactivity and impulsivity: difficulty sitting still, interrupting, making decisions quickly without full consideration of consequences. Many people experience a combination. The clinical picture also looks different across developmental stages — hyperactivity that was visible in childhood may present as internal restlessness in adulthood.

ADHD is underdiagnosed in certain populations. Women and people assigned female at birth are less likely to receive ADHD diagnoses in childhood, partly because inattentive presentations are less disruptive and therefore less noticed. People who have developed significant coping strategies — sometimes called masking — may not present obviously despite real impairment. Many adults receive a diagnosis only when seeking help for other concerns, including substance use.

ADHD and Substance Use: What the Research Shows

ADHD and substance use disorder co-occur at higher rates than chance. Research consistently finds that people with ADHD are at elevated risk for developing substance use disorders, and that adults in substance use treatment have higher rates of ADHD than the general population. A meta-analytic review of prospective studies found that childhood ADHD significantly increased the odds of a substance use disorder in adulthood (Lee et al., 2011).

Several mechanisms are proposed for this connection:

  • Impulsivity: Impulsivity is a core feature of ADHD and a significant factor in substance use initiation and escalation. Difficulty pausing before acting, weighing longer-term consequences, and tolerating discomfort all increase vulnerability to problematic substance use.
  • Self-medication: Some people with undiagnosed or undertreated ADHD find that certain substances temporarily reduce the experience of inattention, restlessness, or the distress of failing to meet expectations. This pattern may develop without deliberate intent, as the substance provides relief — however temporary — from experiences that feel unmanageable.
  • Reward processing differences: ADHD involves differences in dopamine regulation that affect how reward, motivation, and delayed gratification are experienced. Substances that rapidly affect dopamine may be more reinforcing for people with these underlying differences.
  • Shared neurobiological factors: ADHD and some substance use disorders share genetic and neurobiological vulnerabilities — meaning they can co-occur not only because one leads to the other, but because they have overlapping underlying roots.

Research on prescribed ADHD medication and later substance use outcomes is mixed and context-dependent. A meta-analysis examining stimulant medication and substance use outcomes found no significant association between ADHD medication use and increased or decreased rates of substance use disorders (Humphreys, Eng & Lee, 2013). The concern that stimulant treatment straightforwardly raises addiction risk is not supported by the available evidence; at the same time, medication is one component of a broader clinical picture that includes the severity and type of ADHD, co-occurring conditions, and the individual’s context. Clinical treatment decisions are made on the basis of individual assessment. The misuse of stimulant medications — using them without a prescription or in ways other than prescribed — is a distinct issue from the clinical treatment of ADHD.

Diagnosis in the Context of Substance Use

Accurate assessment when both ADHD and substance use are present requires clinical care. Substance use can produce or worsen symptoms that overlap with ADHD — including concentration difficulty, impulsivity, sleep disruption, and mood instability. Distinguishing ADHD from substance-induced cognitive and behavioral symptoms typically requires a careful developmental history to establish whether ADHD symptoms were present before substance use began, along with clinical assessment that considers both conditions simultaneously.

This complexity is a reason that clinical assessment typically considers both conditions together rather than treating them as separate tracks. When both ADHD and substance use are present, addressing only one without accounting for the other can leave significant factors unaddressed. Assessment can identify how each condition is interacting with the other and guide a coordinated treatment plan that considers both.

LGBTQ+ People and ADHD

There is emerging interest in the relationship between LGBTQ+ identity and ADHD, though the research base is limited and the evidence on prevalence differences is not yet established. What is clearer is that LGBTQ+ people may face specific barriers to accurate ADHD assessment — including providers who may attribute executive function difficulties to anxiety, depression, or identity-related stress without considering ADHD. Masking — developing strategies to compensate for and conceal ADHD symptoms — may be relevant for people who have also learned to manage how they present in other areas of life, though the degree of overlap is not well-quantified.

For LGBTQ+ people with co-occurring ADHD and substance use, treatment in an affirming environment matters. Not because LGBTQ+ identity is the clinical problem, but because an environment where identity does not need to be managed or explained frees clinical attention for what actually needs it.

Treatment at Inspire Recovery

Inspire Recovery is a licensed and accredited LGBTQ+-affirming outpatient treatment center in West Palm Beach, Florida. When ADHD is part of the clinical picture alongside substance use, the treatment approach addresses both within an integrated plan. Clinical assessment determines the appropriate level of care — PHP, IOP, or standard outpatient — as well as the specific therapeutic approaches that fit.

Substance use treatment at Inspire Recovery includes evidence-based approaches that are relevant for co-occurring ADHD: structured behavioral therapies that support executive function, strategies for managing impulsivity and distress tolerance, and a clinical environment that understands how ADHD can affect engagement with treatment itself. Individual therapy and LGBTQ+-affirming group therapy are both part of how treatment works here.

Our co-occurring disorders treatment page describes how integrated care works at Inspire Recovery more broadly. If ADHD and substance use are both part of your experience and you want to understand what treatment could look like, our admissions team can listen and help.

Starting a Conversation

Many people with ADHD reach adulthood without a diagnosis and without understanding why certain things have always been harder. A substance use treatment conversation can be the first time someone makes sense of a pattern that has been present their whole life. That is not unusual, and it does not require that everything be figured out before you call.

The admissions conversation is where you describe what is going on and ask questions — with no pressure and no obligation.

561-725-9877 | Verify Your Insurance

Sources: Lee SS et al., 2011 (Clin Psychol Rev 31(3):328–341 — Prospective association of childhood ADHD and substance use and abuse/dependence: A meta-analytic review) | Humphreys KL, Eng T, Lee SS, 2013 (JAMA Psychiatry 70(7):740–749 — Stimulant medication and substance use outcomes: a meta-analysis)